Telmisartan improves abnormal vasorelaxation in mesenteric arteries of SHR/NDmcr-cp rats, an animal model of metabolic syndrome

被引：0
|
作者：
Kagota, Satomi [1 ]
Tada, Yukari [1 ]
Nejime, Namie [1 ]
Nakamura, Kazuki [1 ]
Kunitomo, Masaru [1 ]
Shinozuka, Kazumasa [1 ]
机构：
[1] Mukogawa Womens Univ, Sch Pharmaceut Sci, Dept Pharmacol, Nishinomiya, Hyogo 6638179, Japan
来源：
JOURNAL OF PHARMACOLOGICAL SCIENCES | 2007年 / 103卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：77P / 77P
页数：1
相关论文
共 43 条
  • [31] Flax oil-mediated activation of PPAR-γ correlates with reduction of hepatic lipid accumulation in obese spontaneously hypertensive/NDmcr-cp rats, a model of the metabolic syndrome
    Chechi, Kanta
    Yasui, Naomi
    Ikeda, Katsumi
    Yamori, Yukio
    Cheema, Sukhinder K.
    BRITISH JOURNAL OF NUTRITION, 2010, 104 (09) : 1313 - 1321
  • [32] Investigation and Assessment of Biological Beneficial Substances Using Metabolic Syndrome Model Rats (SHR.Cg-Leprcp/NDmcr)
    Katakura, M.
    Hashimoto, M.
    CLINICAL AND EXPERIMENTAL HYPERTENSION, 2009, 31 (06) : 494 - 494
  • [33] Genetic analysis of the spontaneously hypertensive rats (SHR), an animal model of metabolic syndrome
    Gotoda, T
    Iizuka, Y
    Osuga, J
    Kato, N
    Kapoor, V
    Shimano, H
    Ishibashi, S
    Iwamoto, Y
    Yamada, N
    ATHEROSCLEROSIS SUPPLEMENTS, 2003, 4 (02) : 48 - 48
  • [34] Angiotensin II type 1 receptor antagonists prevent abnormal vasorelaxation in mesenteric artery of SHRSP.Z-Leprfa/IzmDmcr rats, a new animal model of metabolic syndrome
    Kagota, Satomi
    Tada, Yukari
    Nejime, Namie
    Nakamura, Kazuki
    Kunitomo, Masaru
    Shinozuka, Kazumasa
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2008, 106 : 87P - 87P
  • [35] Effects of hydrogen-rich water on abnormalities in a SHR.Cg-Lepr(cp)/NDmcr rat - a metabolic syndrome rat model
    Hashimoto, Michio
    Katakura, Masanori
    Nabika, Toru
    Tanabe, Yoko
    Hossain, Shahdat
    Tsuchikura, Satoru
    Shido, Osamu
    MEDICAL GAS RESEARCH, 2011, 1
  • [36] Abnormal vasorelaxation in the mesenteric artery of SHRSP.Z-Lepifa/IzmDmcr rats, a new animal model of metabolic syndrome, and improved effects of angiotensin II type I receptor antagonist.
    Kagota, Satomi
    Tada, Yukari
    Nejime, Namie
    Nakamura, Kazuki
    Kunitomo, Masaru
    Shinozuka, Kazumasa
    YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN, 2007, 127 : 216 - 219
  • [37] Angiotensin II type 1 receptor antagonist ameriorates abnormal vasorelaxation in SHRSP. ZF rats, a new animal model of metabolic syndrome
    Kagota, S.
    Tada, Y.
    Fukushima, K.
    Umetani, K.
    Yamaguchi, Y.
    Nose, N.
    Mori, H.
    Kunitomo, M.
    Shinozuka, K.
    JOURNAL OF HYPERTENSION, 2008, 26 : S513 - S514
  • [38] Characteristics of lipolysis in white adipose tissues of SHR/NDmc-cp rats, a model of metabolic syndrome
    Harikai, Naoki
    Hashimoto, Ayu
    Semma, Masanori
    Ichikawa, Atsushi
    METABOLISM-CLINICAL AND EXPERIMENTAL, 2007, 56 (06): : 847 - 855
  • [39] Effect of supplementation of EPA and DHA prescription on atorvastatin-induced decrease in fatty acids of SHR.Cg-Leprcp/NDmcr rats, a metabolic syndrome model
    Hashimoto, Michio
    Al Abdullah, Mamun
    Katakura, Masanori
    Tanabe, Yoko
    Shido, Osamu
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2016, 130 (03) : S179 - S179
  • [40] Effect of dietary n-3 fatty acids supplementation on fatty acid metabolism in atorvastatin-administered SHR.Cg-Leprcp/NDmcr rats, a metabolic syndrome model
    Al Mamun, Abdullah
    Hashimoto, Michio
    Katakura, Masanori
    Tanabe, Yoko
    Tsuchikura, Satoru
    Hossain, Shahdat
    Shido, Osamu
    BIOMEDICINE & PHARMACOTHERAPY, 2017, 85 : 372 - 379
12345